We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The companies paying for large media coverage during their technologies infancy is a waste of money IMO. I've already forgotten the names of those companies hoping to, started to, and will be etc. Save the costly media promotions for when we can say, " MictrotoxBT, tested in numerous hospitals, proven in Cat3 labs and verified on 5,000 patients, is now available to purchase. Anything prior to that is just speculative news that may attract a few investors. In fact press coverage will be free at that point as the media will be queuing up to interview DV.
Hopefully the merger will allow a lot more joined up PR to be released. No need for different company names, just Deepverge getting the headlines with all subsidiaries just getting mentioned in the article details.
This will help hun.............!
https://www.lse.co.uk/rns/DVRG/comment-on-detection-of-covid-19-in-uk-sewage-tdaa1yen0o2601j.html
And nice shout, sure we're global.......... :()
All the best (would you like the US lakes one.......... :()
To be honest I don't know if GB is interested in the UK market at all for below or above ground testing. Maybe he has bigger fish frying outside the UK Market?
Every time I pick up national newspapers I see reference to different companies developing breath tests.
It was great too see some positive news in the Irish Examiner but seeing the importance of this project, would it be wise for DV to step up their game on the PR front. Yes it will require some investment but surely now is the time to engage a full on PR company to get DVs names mentioned in the same line as these other foreign companies and attract world wide interest.
It’s also seems from the IE article that DVs accuracy and in-field testing are slightly ahead than the others than previously may have been disclosed..
I really don’t think the current PR company is doing justice to DV. Maybe there is a lot behind the scenes but how are other small start ups and companies getting this attention while DV seemingly gets ignored.
Anyway onwards and upwards and hope DV all the success...